eHealth, Inc. (EHTH) stock

EHTHNasdaqInsurance Agents, Brokers & ServiceFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30

$0.41−0.03 (-5.95%)

Close on Nov 13, 2026Market cap $13.26MP/E –Yield –

Earnings

eHealth's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Feb 24, 2027

Q4 FY2026 · estimated, after the close

Revenue, Q3 FY2026

$21.28M

-60.5% on a year earlier

Adjusted EPS, Q3 FY2026

-$1.57

Latest guidance

Lowered

Nov 4, 2026 · 4 items

Quarterly results

Revenue and earnings per share from each of eHealth's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q4 FY2026ended Dec 31, 2026	Feb 24, 2027Expected	–	–	–	–	–
Q3 FY2026ended Sep 30, 2026	Nov 4, 2026after the close	$21.28M	-60.5%	-$1.57	–	Release
Q2 FY2026ended Jun 30, 2026	Aug 4, 2026after the close	–	–	–	–	Release
Q1 FY2026ended Mar 31, 2026	May 6, 2026after the close	$88.00M	-22.2%	-$0.58	–	Release
Q4 FY2025ended Dec 31, 2025	Feb 25, 2026after the close	$326.20M	+3.5%	$2.06	–	Release
Q3 FY2025ended Sep 30, 2025	Nov 5, 2025after the close	$53.90M	-7.7%	–	–	Release
Q2 FY2025ended Jun 30, 2025	Aug 6, 2025before the open	$60.80M	-7.7%	–	–	Release
Q1 FY2025ended Mar 31, 2025	May 7, 2025before the open	$113.10M	+21.6%	-$0.33	–	Release
Q4 FY2024ended Dec 31, 2024	Feb 26, 2025before the open	$315.20M	+27.3%	$2.51	–	Release
Q3 FY2024ended Sep 30, 2024	Nov 6, 2024before the open	$58.40M	-9.7%	–	–	Release
Q2 FY2024ended Jun 30, 2024	Aug 7, 2024before the open	$65.90M	-1.3%	-$1.33	–	Release
Q1 FY2024ended Mar 31, 2024	May 7, 2024before the open	$93.00M	+26.2%	-$0.96	–	Release
Q4 FY2023ended Dec 31, 2023	Feb 27, 2024before the open	$247.70M	+26.2%	$1.27	–	Release
Q3 FY2023ended Sep 30, 2023	Nov 8, 2023after the close	$64.70M	+21.2%	-$1.68	–	Release
Q2 FY2023ended Jun 30, 2023	Aug 8, 2023before the open	$66.80M	+32.5%	-$1.18	–	Release
Q1 FY2023ended Mar 31, 2023	May 9, 2023before the open	$73.70M	-30.0%	-$1.01	–	Release
Q4 FY2022ended Dec 31, 2022	Feb 28, 2023before the open	$196.32M	-19.4%	$0.41	$1.14	Release
Q3 FY2022ended Sep 30, 2022	Nov 7, 2022after the close	$53.38M	-16.5%	-$1.72	-$1.17	Release
Q2 FY2022ended Jun 30, 2022	Aug 8, 2022after the close	$50.41M	–	-$1.65	-$1.15	Release
Q1 FY2022ended Mar 31, 2022	May 3, 2022after the close	$105.30M	–	-$1.46	-$0.91	Release
Q4 FY2021ended Dec 31, 2021	Mar 1, 2022before the open	$243.50M	–	-$1.45	$0.49	Release
Q3 FY2021ended Sep 30, 2021	Nov 8, 2021before the open	$63.90M	–	-$2.24	-$1.78	Release
Q2 FY2021ended Jun 30, 2021	Jul 29, 2021after the close	–	–	–	–	Filing
Q1 FY2021ended Mar 31, 2021	Apr 29, 2021after the close	–	–	–	–	Filing
Q4 FY2020ended Dec 31, 2020	Jan 29, 2021before the open	–	–	–	–	Filing
Q3 FY2020ended Sep 30, 2020	Oct 22, 2020after the close	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

eHealth's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
Total revenueGAAP	FY2026	$405.00M – $445.00M	–	New	Nov 4, 2026
Total revenue	FY2026	$405.00M – $445.00M	$8.00M – $20.00M	Raised	Aug 4, 2026
Total revenueGAAP	FY2026	$405.00M – $445.00M	–	New	May 6, 2026
Adjusted EBITDAnon-GAAP	FY2026	$55.00M – $75.00M	$55.00M – $75.00M	Reaffirmed	Aug 4, 2026
Adjusted EBITDA (1)non-GAAP	FY2026	$55.00M – $75.00M	–	New	Nov 4, 2026
GAAP net incomeGAAP	FY2026	$8.00M – $25.00M	–	New	Nov 4, 2026
GAAP net incomeGAAP	FY2026	$8.00M – $25.00M	$8.00M – $25.00M	Raised	Aug 4, 2026
Operating cash flowGAAP	FY2026	-$10.00M – $12.00M	–	Lowered	Nov 4, 2026
Operating cash flow	FY2026	-$10.00M – $12.00M	-$10.00M – $12.00M	Lowered	Aug 4, 2026
Operating cash flowGAAP	FY2026	-$10.00M – $12.00M	–	Lowered	May 6, 2026
positive net adjustment revenue	FY2026	$16.00M – $20.00M	$0 – $20.00M	Raised	Aug 4, 2026

Guidance vs results

The last range eHealth gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2025	Revenue	$525.00M – $565.00M	$554.00MΣ4Q	Within range

Guidance history

Every forecast eHealth put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Nov 4, 2026	Adjusted EBITDA (1)	FY2026	$55.00M – $75.00M	New
Nov 4, 2026	GAAP net income	FY2026	$8.00M – $25.00M	New
Nov 4, 2026	Operating cash flow	FY2026	-$10.00M – $12.00M	Lowered
Nov 4, 2026	Total revenue	FY2026	$405.00M – $445.00M	New
Aug 4, 2026	Adjusted EBITDA	FY2026	$55.00M – $75.00M	Reaffirmed
Aug 4, 2026	Operating cash flow	FY2026	-$10.00M – $12.00M	Lowered
Aug 4, 2026	positive net adjustment revenue	FY2026	$16.00M – $20.00M	Raised
Aug 4, 2026	GAAP net income	FY2026	$8.00M – $25.00M	Raised
Aug 4, 2026	Total revenue	FY2026	$405.00M – $445.00M	Raised
May 6, 2026	Adjusted EBITDA	FY2026	$55.00M – $75.00M	Reaffirmed
May 6, 2026	GAAP net income	FY2026	$8.00M – $25.00M	Reaffirmed
May 6, 2026	Operating cash flow	FY2026	-$10.00M – $12.00M	Lowered
May 6, 2026	positive net adjustment revenue	FY2026	$8.00M – $20.00M	Lowered
May 6, 2026	Total revenue	FY2026	$405.00M – $445.00M	New
Feb 25, 2026	Adjusted EBITDA	FY2026	$55.00M – $75.00M	New
Feb 25, 2026	Operating cash flow	FY2026	-$10.00M – $12.00M	New
Feb 25, 2026	positive net adjustment revenue	FY2026	$0 – $20.00M	Raised
Feb 25, 2026	GAAP net income	FY2026	$8.00M – $25.00M	New
Feb 25, 2026	Total revenue	FY2026	$405.00M – $445.00M	New
Nov 5, 2025	Adjusted EBITDA (1)	FY2025	$60.00M – $80.00M	New
Nov 5, 2025	Operating cash flow	FY2025	-$25.00M – $10.00M	New
Nov 5, 2025	positive net adjustment revenue	FY2025	$40.00M – $43.00M	Raised
Nov 5, 2025	GAAP net income	FY2025	$9.00M – $30.00M	New
Nov 5, 2025	Total revenue	FY2025	$525.00M – $565.00M	New
Aug 6, 2025	Adjusted EBITDA (1)	FY2025	$55.00M – $75.00M	Raised
Aug 6, 2025	Operating cash flow	FY2025	-$25.00M – $10.00M	Reaffirmed
Aug 6, 2025	positive net adjustment revenue	FY2025	$29.00M – $32.00M	Raised
Aug 6, 2025	GAAP net income	FY2025	$5.00M – $26.00M	Raised
Aug 6, 2025	Total revenue	FY2025	$525.00M – $565.00M	Raised
May 7, 2025	Adjusted EBITDA	FY2025	$35.00M – $60.00M	Reaffirmed
May 7, 2025	GAAP net income (loss)	FY2025	-$10.00M – $15.00M	Reaffirmed
May 7, 2025	Operating cash flow	FY2025	-$25.00M – $10.00M	Lowered
May 7, 2025	positive net adjustment revenue	FY2025	$11.00M – $20.00M	New
May 7, 2025	Total revenue	FY2025	$510.00M – $550.00M	New
Feb 26, 2025	Adjusted EBITDA (1)	FY2025	$35.00M – $60.00M	New
Feb 26, 2025	Operating cash flow	FY2025	-$25.00M – $10.00M	New
Feb 26, 2025	GAAP net income (loss)	FY2025	-$10.00M – $15.00M	New
Feb 26, 2025	Total revenue	FY2025	$510.00M – $550.00M	New
Feb 26, 2025	positive net adjustment revenue	FY2025	$0 – $20.00M	Lowered
Nov 6, 2024	Adjusted EBITDA	FY2024	$7.50M – $25.00M	Reaffirmed
Nov 6, 2024	Operating cash flow	FY2024	-$10.00M – $0	Raised
Nov 6, 2024	positive net adjustment revenue	FY2024	$14.00M – $20.00M	Raised
Nov 6, 2024	GAAP net income (loss)	FY2024	-$36.50M – -$22.00M	Lowered
Nov 6, 2024	growth in Non-GAAP total revenue excluding net adjustment revenue	FY2024	+15%	New
Nov 6, 2024	Total revenue	FY2024	$470.00M – $495.00M	Reaffirmed
Aug 7, 2024	Adjusted EBITDA	FY2024	$7.50M – $25.00M	Raised
Aug 7, 2024	GAAP net income (loss)	FY2024	-$36.50M – -$22.00M	Narrowed
Aug 7, 2024	Operating cash flow	FY2024	-$10.00M – $0	Raised
Aug 7, 2024	Total revenue	FY2024	$470.00M – $495.00M	New
May 7, 2024	Adjusted EBITDA	FY2024	-$5.00M – $20.00M	Reaffirmed
May 7, 2024	Operating cash flow	FY2024	-$15.00M – -$5.00M	Reaffirmed
May 7, 2024	GAAP net income (loss)	FY2024	-$40.00M – -$20.00M	Reaffirmed
May 7, 2024	Total revenue	FY2024	$450.00M – $475.00M	Reaffirmed
Feb 27, 2024	Adjusted EBITDA (1)	FY2024	-$5.00M – $20.00M	New
Feb 27, 2024	Operating cash flow	FY2024	-$15.00M – -$5.00M	New
Feb 27, 2024	GAAP net income (loss)	FY2024	-$40.00M – -$20.00M	New
Feb 27, 2024	Total revenue	FY2024	$450.00M – $475.00M	New
Nov 8, 2023	Adjusted EBITDA	FY2023	-$3.00M – $17.00M	Reaffirmed
Nov 8, 2023	Operating cash flow	FY2023	-$30.00M – -$15.00M	Reaffirmed
Nov 8, 2023	GAAP net loss	FY2023	-$46.00M – -$26.00M	Reaffirmed
Nov 8, 2023	Total revenue	FY2023	$439.00M – $459.00M	Reaffirmed
Aug 8, 2023	Adjusted EBITDA	FY2023	-$3.00M – $17.00M	Raised
Aug 8, 2023	Operating cash flow	FY2023	-$30.00M – -$15.00M	Reaffirmed
Aug 8, 2023	GAAP net loss	FY2023	-$46.00M – -$26.00M	Raised
Aug 8, 2023	Total revenue	FY2023	$439.00M – $459.00M	Raised
May 9, 2023	Adjusted EBITDA	FY2023	-$15.00M – $5.00M	Reaffirmed
May 9, 2023	Operating cash flow	FY2023	-$30.00M – -$15.00M	Reaffirmed
May 9, 2023	GAAP net loss	FY2023	-$55.00M – -$35.00M	Lowered
May 9, 2023	Total revenue	FY2023	$420.00M – $440.00M	Reaffirmed
Feb 28, 2023	Adjusted EBITDA	FY2023	-$15.00M – $5.00M	New
Feb 28, 2023	Operating cash flow	FY2023	-$30.00M – -$15.00M	New
Feb 28, 2023	GAAP net loss	FY2023	$35.00M – $55.00M	New
Feb 28, 2023	Total revenue	FY2023	$420.00M – $440.00M	New
Nov 7, 2022	Adjusted EBITDA	FY2022	-$73.00M – -$45.00M	Reaffirmed
Nov 7, 2022	GAAP net loss	FY2022	-$115.00M – -$92.00M	Lowered
Nov 7, 2022	Total cash outflow, excluding the impact of our $70.0 million term loan and associated costs and net securities activities	FY2022	-$110.00M – -$90.00M	Lowered
Nov 7, 2022	Total revenue	FY2022	$375.00M – $395.00M	Reaffirmed
Aug 8, 2022	Adjusted EBITDA	FY2022	-$73.00M – -$45.00M	Lowered
Aug 8, 2022	Total cash outflow	FY2022	$90.00M – $110.00M	Lowered
Aug 8, 2022	GAAP net loss	FY2022	$92.00M – $115.00M	Raised
Aug 8, 2022	Total revenue	FY2022	$375.00M – $395.00M	New
May 3, 2022	Adjusted EBITDA	FY2022	-$64.00M – -$37.00M	Reaffirmed
May 3, 2022	GAAP net loss	FY2022	-$106.00M – -$83.00M	Lowered
May 3, 2022	Total cash outflow, excluding the impact of our $70.0 million term loan and associated costs	FY2022	$120.00M – $140.00M	New
May 3, 2022	Total revenue	FY2022	$448.00M – $470.00M	Reaffirmed
Mar 1, 2022	Adjusted EBITDA	FY2022	-$64.00M – -$37.00M	New
Mar 1, 2022	Total cash outflow	FY2022	$120.00M – $140.00M	New
Mar 1, 2022	GAAP net loss	FY2022	$124.00M – $147.00M	New
Mar 1, 2022	Total revenue	FY2022	$448.00M – $470.00M	New
Nov 8, 2021	cash used for capital expenditures	FY2021	$21.00M – $24.00M	New
Nov 8, 2021	Adjusted EBITDA	FY2021	-$20.00M – $0	New
Nov 8, 2021	Non-GAAP net loss per diluted share	FY2021	-$1.13 – -$0.45	New
Nov 8, 2021	GAAP net loss attributable to common stockholders per diluted share	FY2021	-$2.99 – -$2.26	New
Nov 8, 2021	Cash used in operations	FY2021	$125.00M – $135.00M	New
Nov 8, 2021	GAAP net loss	FY2021	-$63.00M – -$43.00M	New
Nov 8, 2021	Medicare segment profit (loss)	FY2021	-$5.00M – $16.00M	New
Nov 8, 2021	Individual, Family and Small Business segment profit	FY2021	$41.00M – $43.00M	Raised
Nov 8, 2021	Corporate shared service expenses, excluding stock-based compensation, depreciation and amortization expense, and restructuring and reorganization charges	FY2021	$56.00M – $59.00M	Raised
Nov 8, 2021	Total revenue	FY2021	$535.00M – $575.00M	New
Nov 8, 2021	Revenue from the Medicare segment	FY2021	$471.00M – $509.00M	Lowered
Nov 8, 2021	Revenue from the Individual, Family and Small Business segment	FY2021	$64.00M – $66.00M	Lowered

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.